Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Msdc-0160
1. 146062-49-9
2. Msdc-0160
3. Cay10415
4. 5-(4-(2-(5-ethylpyridin-2-yl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione
5. Msdc 0160
6. Cay 10415
7. Cay-10415
8. Msd-9
9. 29i7rp18rg
10. Msdc0160
11. U-91325
12. 5-(4-(2-(5-ethylpyridin-2-yl)-2-oxoethoxy)-benzyl)thiazolidine-2,4-dione
13. Pnu-91325
14. J730.386f
15. 2,4-thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)-2-oxoethoxy]phenyl]methyl]-
16. 5-[[4-[2-(5-ethylpyridin-2-yl)-2-oxoethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
17. Unii-29i7rp18rg
18. 2,4-thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)-2-oxoethoxy)phenyl)methyl)-
19. 5-({4-[2-(5-ethylpyridin-2-yl)-2-oxoethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione
20. Schembl622605
21. Us9562012, Mitoglitazone
22. Chembl146624
23. Schembl18538169
24. Chebi:94409
25. Gtpl11303
26. Mitoglitazone, >=98% (hplc)
27. Bdbm228129
28. Dtxsid301317736
29. Bcp16099
30. Ex-a1483
31. Wfa06249
32. Mfcd00916084
33. S7453
34. Akos026750561
35. Cs-6405
36. Db11721
37. Sb17325
38. Cay10415(msdc-0160)
39. Msdc-0160(cay10415)
40. Ac-32632
41. As-73799
42. Hy-100550
43. A899267
44. J-008189
45. Brd-a61858259-001-01-0
46. Q27166263
47. 5-[4-[2-(5-ethyl-2-pyridyl)-2-oxoethoxy]benzyl]-2,4-thiazolidinedione
48. 5-(4-(2-(5-ethyl-2-pyridinyl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione
49. 5-[[4-[2-(5-ethyl-2-pyridinyl)-2-oxoethoxy]phenyl]methyl]-2,4-thiazolidinedione
50. 5-{4-[2-(5-ethylpyridin-2-yl)-2-oxoethoxy]benzyl}-1,3-thiazolidine-2,4-dione
51. 5- [[4- [2- (5- Ethyl- 2- Pyridinyl)- 2-oxoethoxy]phenyl]methyl]- 2, 4-thiazolidinedione
52. 5-[[4-[2-(5-ethyl-2-pyridinyl)-2-oxoethoxy]phenyl]methyl]-2,4-thiazolidinedione;msdc-0160
| Molecular Weight | 370.4 g/mol |
|---|---|
| Molecular Formula | C19H18N2O4S |
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 7 |
| Exact Mass | 370.09872823 g/mol |
| Monoisotopic Mass | 370.09872823 g/mol |
| Topological Polar Surface Area | 111 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 534 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
80
PharmaCompass offers a list of Mitoglitazone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mitoglitazone manufacturer or Mitoglitazone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mitoglitazone manufacturer or Mitoglitazone supplier.
PharmaCompass also assists you with knowing the Mitoglitazone API Price utilized in the formulation of products. Mitoglitazone API Price is not always fixed or binding as the Mitoglitazone Price is obtained through a variety of data sources. The Mitoglitazone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mitoglitazone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mitoglitazone, including repackagers and relabelers. The FDA regulates Mitoglitazone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mitoglitazone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mitoglitazone supplier is an individual or a company that provides Mitoglitazone active pharmaceutical ingredient (API) or Mitoglitazone finished formulations upon request. The Mitoglitazone suppliers may include Mitoglitazone API manufacturers, exporters, distributors and traders.
Mitoglitazone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mitoglitazone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mitoglitazone GMP manufacturer or Mitoglitazone GMP API supplier for your needs.
A Mitoglitazone CoA (Certificate of Analysis) is a formal document that attests to Mitoglitazone's compliance with Mitoglitazone specifications and serves as a tool for batch-level quality control.
Mitoglitazone CoA mostly includes findings from lab analyses of a specific batch. For each Mitoglitazone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mitoglitazone may be tested according to a variety of international standards, such as European Pharmacopoeia (Mitoglitazone EP), Mitoglitazone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mitoglitazone USP).
